Wang Lexun, Feng Jiaojiao, Deng Yanyue, Yang Qianqian, Wei Quxing, Ye Dewei, Rong Xianglu, Guo Jiao
Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, China.
Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, China.
Research (Wash D C). 2022 Oct 3;2022:9891689. doi: 10.34133/2022/9891689. eCollection 2022.
CCAAT/enhancer-binding proteins (C/EBPs) are a family of at least six identified transcription factors that contain a highly conserved basic leucine zipper domain and interact selectively with duplex DNA to regulate target gene expression. C/EBPs play important roles in various physiological processes, and their abnormal function can lead to various diseases. Recently, accumulating evidence has demonstrated that aberrant C/EBP expression or activity is closely associated with the onset and progression of fibrosis in several organs and tissues. During fibrosis, various C/EBPs can exert distinct functions in the same organ, while the same C/EBP can exert distinct functions in different organs. Modulating C/EBP expression or activity could regulate various molecular processes to alleviate fibrosis in multiple organs; therefore, novel C/EBPs-based therapeutic methods for treating fibrosis have attracted considerable attention. In this review, we will explore the features of C/EBPs and their critical functions in fibrosis in order to highlight new avenues for the development of novel therapies targeting C/EBPs.
CCAAT/增强子结合蛋白(C/EBPs)是一个由至少六种已鉴定的转录因子组成的家族,这些转录因子含有高度保守的碱性亮氨酸拉链结构域,并与双链DNA选择性相互作用以调节靶基因表达。C/EBPs在各种生理过程中发挥重要作用,其功能异常可导致多种疾病。最近,越来越多的证据表明,C/EBP表达或活性异常与多个器官和组织纤维化的发生和进展密切相关。在纤维化过程中,各种C/EBPs可在同一器官中发挥不同功能,而同一C/EBP可在不同器官中发挥不同功能。调节C/EBP表达或活性可调控多种分子过程,以减轻多个器官的纤维化;因此,基于C/EBPs的新型抗纤维化治疗方法已引起广泛关注。在本综述中,我们将探讨C/EBPs的特征及其在纤维化中的关键作用,以突出针对C/EBPs开发新型疗法的新途径。